Current Vascular Pharmacology

Papers
(The TQCC of Current Vascular Pharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside24
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports23
Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions23
Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?21
Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives20
Lifestyle, Maternal Nutrition and Healthy Pregnancy20
Endothelial Dysfunction and Inflammatory Markers of Vascular Disease19
Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways19
Coronary Calcium Risk Score and Cardiovascular Risk18
The Burden of Cardiovascular Disease Risk Factors in the Middle East: A Systematic Review and Meta-Analysis Focusing on Primary Prevention18
Metabolic Adaptations to Pregnancy in Healthy and Gestational Diabetic Pregnancies: The Pancreas - Placenta Axis18
Pathogenic Mechanisms of Trimethylamine N-Oxide-induced Atherosclerosis and Cardiomyopathy14
The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells14
Effects of Maternal Obesity On Placental Phenotype14
Vitamin D and Vascular Disease13
PCSK9 Inhibitors and Ezetimibe Monotherapy in Patients Not Receiving Statins: A Meta-Analysis of Randomized Trials13
Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis12
The Myometrium in Pregnant Women with Obesity12
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?11
New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients11
Obesity and Gestational Diabetes in Pregnant Care and Clinical Practice9
Cardioprotective Effects of Natural Products via the Nrf2 Signaling Pathway9
Non-Alcoholic Fatty Liver Disease and Vascular Disease9
Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia9
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?9
Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class8
Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)8
Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i8
Pulse Wave Velocity Assessment for Cardiovascular Risk Prognostication in ESKD: Weighting Recent Evidence8
Endocrine Disorders and Peripheral Arterial Disease: A Series of Reviews7
Effect of Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction and with Reduced Ejection Fraction - A Narrative Review7
Assessment and Management of Volume Overload Among Patients on Chronic Dialysis7
Intermittent Fasting as Possible Treatment for Heart Failure7
Effects of Gentiana lutea Root on Vascular Diseases7
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome7
Non-alcoholic Fatty Liver Disease in Children7
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases7
Current Insights on the Role of Irisin in Endothelial Dysfunction6
COVID-19-associated Coagulopathy and Thromboembolism: Determination of Their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients6
Features of a Balanced Healthy Diet with Cardiovascular and Other Benefits6
STOPP/START Anti-aggregation and Anticoagulation Alerts in Atrial Fibrillation6
Male Patients with Takayasu Arteritis and Coronary Artery Involvement are Prone to Have Serious Coronary Stenosis and High Mortality6
Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 16
Interleukin-10 in the Vasculature: Pathophysiological Implications6
Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study5
Cardiovascular Benefits of Extended-Time Nocturnal Hemodialysis5
Efficacy and Safety of Evolocumab in Reducing Low-Density Lipoprotein Cholesterol Levels in Chinese Patients with Non-ST-segment Elevation Acute Coronary Syndrome5
Inflammasomes in the Pathophysiology of Maternal Obesity: Potential Therapeutic Targets to Reduce Long-Term Adverse Health Outcomes in the Mother and Offspring5
Role of Vitamins in Cardiovascular Health: Know Your Facts-Part 25
Contribution of STIM-Activated TRPC-ORAI Channels in Pulmonary Hypertension Induced by Chronic Sustained and Intermittent Hypoxia5
Efficacy and Safety of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus After Acute Anterior Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Intervention5
Vitamin K Supplementation in Chronic Kidney Disease Patients: Where is the Evidence?5
The Prospect of Genomic, Transcriptomic, Epigenetic and Metabolomic Biomarkers for The Personalized Prevention of Type 2 Diabetes and Cardiovascular Diseases5
Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 25
Stromal Cell-Derived Factor (SDF) 2 and the Endoplasmic Reticulum Stress Response of Trophoblast Cells in Gestational Diabetes Mellitus and In vitro Hyperglycaemic Condition5
COVID-19 and Inflammatory Markers5
Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?5
Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes5
0.06163215637207